3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
88
INDUSTRY
58
NIH
5
NETWORK
4
OTHER_GOV
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Conditions
Neoplasm Metastasis
2
Carcinoma, Non-Small-Cell Lung
2
Stomach Neoplasms
1
Sarcopenia
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Interventions
Pemetrexed
6
Cisplatin
6
Nivolumab
5
Gemcitabine
5
Drug Therapy
5
Radiotherapy
4
Docetaxel
4
pembrolizumab
3
Platinum Compounds
3
Immune Checkpoint Inhibitors
3
Endostatins
3
Carboplatin
3
tislelizumab
2
endostar protein
2
durvalumab
2
camrelizumab
2
Thalidomide
2
Paclitaxel
2
Oxaliplatin
2
Irinotecan
2
Gefitinib
2
Erlotinib Hydrochloride
2
Bevacizumab
2
Afatinib
2
trilaciclib
1
toripalimab
1
titanium silicide
1
osimertinib
1
olaparib
1
lorlatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Carcinoma, Non-Small-Cell Lung
×
durvalumab
×
Clear all
NCT03446547
2026-04-14
ASTEROID
Vastra Gotaland Region
Phase 2
Completed
106 enrolled
NCT07192926
2026-02-20
SARCO-CTI
Ankara Etlik City Hospital
Completed
131 enrolled